Topic: "EIRs, SBIRs, and more with BioHealth Innovation, Inc."
Presenters:
- Richard Bendis, President and CEO
- Ethan Byler, Director, Innovation Programs
- Todd Chappell, Entrepreneur-in-Residence, NIH-OTT
- Dr. Ken Malone, Entrepreneur-in-Residence, UMD Ventures
- Ram Aiyar, Entrepreneur-in-Residence, NHLBI
BioHealth Innovation, Inc. (BHI) is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. It is a private-public partnership that connects the Region’s innovation assets to provide integrated technical knowledge, financial means, and entrepreneurial/managerial expertise to turn promise into prosperity for the region while advancing human health.
BHI’s Entrepreneur-in-Residence (EIR) program is designed to be an active partner with research institutions to source, fund, and grow high-potential, early-stage products through project-focused companies. The entrepreneurs in the program support the formation of new companies based upon innovative discoveries in the areas of drugs, vaccines, therapeutics, diagnostics, and medical devices from the intramural research programs at the NIH and Food and Drug Administration (FDA), as well as from universities and businesses.
BHI's Commercial Relevance Program (CRP) offers biohealth companies support in preparing applications for federal funding inclusive of SBIRs, STTRs, and other federal government awards. Companies submit their federal funding concepts and receive pre-proposal feedback to help troubleshoot and strengthen your application. Further support from professional consultants and service providers is available to assist in improving your application.
BHI recently published the Central Maryland BioHealth Entrepreneur's Resource and Finance Guide 2013. The Guide serves as a compendium of resources to biohealth innovators and entrepreneurs working to start and grow new companies and technologies in the region.